期刊文献+

鲍曼不动杆菌对喹诺酮类药物的耐药机制研究 被引量:24

Study on mechanism of quinolones resistance in Acinetobacter baumannii
在线阅读 下载PDF
导出
摘要 目的探讨鲍曼不动杆菌对喹诺酮类药物的耐药机制。方法收集我院2006年5月—2007年2月不同患者痰培养标本中分离的鲍曼不动杆菌80株,剔除重复菌株用肉汤稀释法测定菌株在环丙沙星、含有不同浓度羟基氰氯苯胺(CCCP)的环丙沙星、亚胺培南-西司他丁的MIC。PCR扩增gyrA基因和parC基因并进行酶切分析,选取部分PCR扩增产物进行测序鉴定。荧光定量PCR方法检测环丙沙星敏感株与耐药株的adeBmRNA表达的相对定量。结果鲍曼不动杆菌对环丙沙星的敏感率为15%,随加入CCCP的浓度增高而增加,并接近亚胺培南的敏感率。PCR限制性片段长度多态性(RFLP)分析显示,58株耐药菌中39株gyrA基因不能被Hinf I酶切,23株praC基因不能被Hinf I酶切,敏感株均能被Hinf I酶切,耐药株中的gyrA和parC基因存在突变。环丙沙星耐药菌株的adeBmRNA表达量明显高于敏感菌株。结论鲍曼不动杆菌对喹诺酮类药物耐药除了与gyrA、praC基因突变有关外,还与主动外排泵基因adeBmRNA过表达有关。 Objective To study the mechanism of quinolones resistance in Acinetobacter baumannii.Methods MICs of ciprofloxacin for 80 isolates from sputum were determined by microbroth dilution with presence of CCCP from May 2006 to February 2007.The gyrA and parC genes were amplified by polymerase chain reaction(PCR) and analyzed by restrict fragment length polymorphism(RFLP).The PCR products were sequenced.The gene expression of adeB mRNA was analyzed by real-time PCR.Results The susceptibility rate of A.baumannii to...
出处 《中国感染与化疗杂志》 CAS 2008年第4期266-270,共5页 Chinese Journal of Infection and Chemotherapy
关键词 鲍曼不动杆菌 喹诺酮耐药 GYRA praC adeABC Acinetobacter baumannii Quinolones resistance gyrA parC adeABC
  • 相关文献

参考文献13

  • 1[1]Poole K.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria[J].Antimicrob Agents Chemother,2000,44 (9):2233-2241.
  • 2[2]Vila J,Ruiz J,Goni P,et al.Quinolone-resistance mutations in the topoisomerase IV praC gene of Acinetobacter baumannii[J].J A ntimicrob Chemother,1997,39(6):757-762.
  • 3刘丁,陈萍,俞志海,陈伟.鲍氏不动杆菌耐喹诺酮类药物的机理研究[J].中国抗生素杂志,2003,28(3):168-171. 被引量:16
  • 4[4]Magnet S,Courvalin P,Lambert T.Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454[J].Antimicrob Agents Chemother,2001,45(12):3375-3380.
  • 5[5]Marchand I,Damier-Piolle L,Courvalin P,et al.Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system[J].Antimicrob Agents Chemother,2004,48(9):3298-3304.
  • 6[6]Chu YW,Chau SL,Houang ET.Presence of active efflux systems AdeABC,AdeDE and AdeXYZ in different Acinetobacter genomic DNA groups[J].J Med Microbiol,2006,55(Pt 4):477-478.
  • 7[7]Ruzin A,Keeney D,Bradford PA.AdeABC multidurg efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex[J].J Antimicrob Chemother,2007,59(5):1001-1004.
  • 8[8]Heritier C,Poirel L,Lambert T,et al.Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenenm resistance in Acinetobacter baumannii[J].Antimicrob Agents Chemother,2005,49(8):3198-3202.
  • 9[9]Piddock LJ.Clinically relevant chromosomally encoded multidrug resistance dfflux pumps in bacteria[J].Clin Microbiol Rev,2006,19(2):382-402.
  • 10[10]Higgins PG,Wisplinghoff H,Stefanik D,et al.Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii[J].J Antimicrob Chemother,2004,54(4):821-823.

共引文献15

同被引文献236

引证文献24

二级引证文献308

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部